Your session is about to expire
← Back to Search
Hormone Therapy + SBRT for Prostate Cancer
Study Summary
This trial is testing a new, more focused type of radiotherapy to see if it improves outcomes for patients with cancer who are negative on conventional imaging but positive on PSMA PET scan.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2024 Phase 2 trial • 57 Patients • NCT03004183Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have not had cancer, except for non-melanoma skin or in-situ cancer, in the last 5 years.I have health issues that make hormone therapy or radiation unsuitable for me.My cancer has spread to no more than 3 areas, as shown by a PSMA scan.I have used hormone therapy for prostate cancer over a year ago with the aim to cure.I am fully active or can carry out light work.My prostate cancer is in stage IV, sensitive to hormones, and has a few spread sites not seen on regular scans but visible on a PSMA PET-CT.My prostate cancer has returned, with a rising PSA level, but no new growth in the prostate.All my cancer areas can be safely treated with targeted radiation.My prostate cancer is not responding to hormone therapy.I am older than 18 years.I have been diagnosed with prostate cancer.
- Group 1: Arm 2: SBRT to mets
- Group 2: Arm 1: Standard of Care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any opportunities to become involved in this research endeavor?
"Per the information listed on clinicaltrials.gov, this research is actively enrolling participants and was initially published online on October 27th 2020 with its most recent update occurring December 1st of the same year."
How many individuals are being monitored for this research endeavor?
"Affirmative. Clinicaltrials.gov data suggests that this research is actively recruiting participants, with 30 enrollees needed from one medical facility since the trial's initial posting on October 27th 2020 and its last update in December 1st 2020."
Share this study with friends
Copy Link
Messenger